Home Newsfeeds BTIG Downgrades Signify Health to Neutral

BTIG Downgrades Signify Health to Neutral

BTIG analyst David Larsen downgrades Signify Health (NYSE:SGFY) from Buy to Neutral.

byBenzinga Newsdesk

September 7, 2022

1 minute read

BTIG analyst David Larsen downgrades Signify Health (NYSE:SGFY) from Buy to Neutral.

Media
News

XPeng Bets On Driver Assistance Software In China By 2024, Level Competition With Tesla

By Anusuya Lahiri

March 31, 11:33 AM

On Friday, XPeng Inc (NYSE: XPEV) said it is upgrading its advanced driver assistance software and plans to make all its functions available to drivers across China by 2024.

TSLA

NY Fed President Williams Says There Is Risk Fed May Need To Raise Interest Rates Higher Than Currently Expected; Fed Will Need Restrictive Rates For Some Time To Cool Inflation; Possible That Fed Cuts Rates In 2024, 2025 To Reflect Lower Inflation

By Happy Mohamed

February 14, 4:41 PM

- Reuters

SPY

Why Intelligent Bio Solutions Shares Are Skyrocketing Today

By Nabaparna Bhattacharya

February 2, 1:36 PM

Intelligent Bio Solutions witnesses a significant surge, expecting a 337% YoY revenue increase for H2 2023 and a 114% increase in Q2, attributing the growth to drug screening solution awareness, market expansion, and global footprint extension.

INBS

Arcelormittal Announces The Publication Of Its Q4 2022 Sell-Side Analyst Consensus Figures; EBITDA $1.257B, Net income $358M, EPS $0.38

By Happy Mohamed

January 27, 1:04 PM

ArcelorMittal today announces the publication of its fourth quarter 2022 sell-side analysts' consensus figures. The consensus figures are based on analysts' estimates recorded on an external web-based

BTIG Downgrades Signify Health to Neutral

Related Posts

XPeng Bets On Driver Assistance Software In China By 2024, Level Competition With Tesla

NY Fed President Williams Says There Is Risk Fed May Need To Raise Interest Rates Higher Than Currently Expected; Fed Will Need Restrictive Rates For Some Time To Cool Inflation; Possible That Fed Cuts Rates In 2024, 2025 To Reflect Lower Inflation

Why Intelligent Bio Solutions Shares Are Skyrocketing Today

Arcelormittal Announces The Publication Of Its Q4 2022 Sell-Side Analyst Consensus Figures; EBITDA $1.257B, Net income $358M, EPS $0.38